Works matching Drug patents
Results: 1885
İLAÇ PATENTLERİNE KARŞI AÇILACAK MENFİ TESPİT DAVALARINDA JENERİK/EŞDEĞER İLACIN RUHSATLANDIRILMASI ŞART MIDIR?
- Published in:
- ASBU Law Journal, 2024, v. 6, n. 2, p. 2269, doi. 10.47136/asbuhfd.1567682
- By:
- Publication type:
- Article
Chemical Variations among Shengmaisan-Based TCM Patent Drugs by Ultra-High Performance Liquid Chromatography Coupled with Hybrid Quadrupole Orbitrap Mass Spectrometry.
- Published in:
- Molecules, 2021, v. 26, n. 13, p. 4000, doi. 10.3390/molecules26134000
- By:
- Publication type:
- Article
Ticaretle Bağlantılı Fikrî Mülkiyet Hakları Anlaşması Çerçevesinde İlaç Patentlerinde Zorunlu Lisans ve Covid-19 Döneminde Yaşanan Bazı Gelişmeler.
- Published in:
- Ankara Barosu Dergileri, 2023, v. 81, n. 3, p. 103, doi. 10.30915/abd.1141298
- By:
- Publication type:
- Article
The reform of drug patent system in Thailand.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2017, v. 41, n. 1, p. 30
- By:
- Publication type:
- Article
Comparison of economic loss between generic drug and patent drug in stock-out and stagnant condition at Surabaya Islamic Hospital, Indonesia.
- Published in:
- Journal of Public Health in Africa, 2019, v. 10, p. 4, doi. 10.4081/jphia.2019.1169
- By:
- Publication type:
- Article
Changing Dimensions of Drug Patents of Indian Pharmaceutical Industry.
- Published in:
- Journal of Intellectual Property Rights, 2018, v. 23, n. 2/3, p. 111
- By:
- Publication type:
- Article
A Look at PTAB Validity Challenges Against GLP-1 Drug Patents.
- Published in:
- Angle Health Law Review, 2024, n. 93, p. 27, doi. 10.53106/24155306202407009
- By:
- Publication type:
- Article
The impact of patent expiry on drug prices: insights from the Dutch market.
- Published in:
- Journal of Market Access & Health Policy, 2021, v. 9, n. 1, p. 1, doi. 10.1080/20016689.2020.1849984
- By:
- Publication type:
- Article
POST-GRANT ADJUDICATION OF DRUG PATENTS: AGENCY AND/OR COURT?
- Published in:
- Berkeley Technology Law Journal, 2022, v. 37, n. 1, p. 139, doi. 10.15779/Z38XK84R4K
- By:
- Publication type:
- Article
A Review on the Drugs Getting Off-Patent between the Years 2022-2025 in USA and Their Pharmaceutical Properties.
- Published in:
- Systematic Reviews in Pharmacy, 2022, v. 13, n. 3, p. 296, doi. 10.31858/0975-8453.13.3.296-305
- By:
- Publication type:
- Article
Needle in a haystack: Harnessing AI in drug patent searches and prediction.
- Published in:
- PLoS ONE, 2024, v. 19, n. 12, p. 1, doi. 10.1371/journal.pone.0311238
- By:
- Publication type:
- Article
Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study.
- Published in:
- International Journal of Health Policy & Management, 2021, v. 10, n. 8, p. 495, doi. 10.34172/ijhpm.2020.100
- By:
- Publication type:
- Article
Effects of Chinese Patent Drug Zishen Pills in Treatment of Elderly Patients with Impaired Glucose Tolerance (IGT).
- Published in:
- Medicinal Plant, 2022, v. 13, n. 6, p. 40, doi. 10.19600/j.cnki.issn2152-3924.2022.06.009
- By:
- Publication type:
- Article
Preferred supplier contracts in post-patent prescription drug markets.
- Published in:
- 2017
- By:
- Publication type:
- journal article
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0379-6
- By:
- Publication type:
- Article
Characteristics and outcomes of the drug patent linkage system in China.
- Published in:
- Globalization & Health, 2024, v. 20, n. 1, p. 1, doi. 10.1186/s12992-024-01035-x
- By:
- Publication type:
- Article
ON THE APPEAL OF DRUG PATENT CHALLENGES.
- Published in:
- American University Law Review, 2023, v. 72, n. 4, p. 1133
- By:
- Publication type:
- Article
Predicting patent challenges for small-molecule drugs: A cross-sectional study.
- Published in:
- PLoS Medicine, 2025, v. 22, n. 2, p. 1, doi. 10.1371/journal.pmed.1004540
- By:
- Publication type:
- Article
Extent of Drug Patents With Terminal Disclaimers and Obviousness-Type Double Patenting Rejections.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 10, p. 837, doi. 10.1001/jama.2024.14350
- By:
- Publication type:
- Article
DISTORTED DRUG PATENTS.
- Published in:
- Washington Law Review, 2020, v. 95, n. 3, p. 1317
- By:
- Publication type:
- Article
South Africa ground zero for reforming drug patents.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2014, v. 186, n. 8, p. E227, doi. 10.1503/cmaj.109-4752
- By:
- Publication type:
- Article
Canadians balk at longer brand-name drug patents.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2014, v. 186, n. 2, p. E69, doi. 10.1503/cmaj.109-4679
- By:
- Publication type:
- Article
Rethinking Ownership, Power and Policy in Drug Patents: The Case for an Ubuntu-Infused Approach.
- Published in:
- Journal of African Law, 2025, v. 69, n. 1, p. 21, doi. 10.1017/S0021855324000263
- By:
- Publication type:
- Article
Senator Urges VA to Nullify Patents for High-Cost Hepatitis C Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2015, v. 314, n. 2, p. 115, doi. 10.1001/jama.2015.7534
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July–September 2023.
- Published in:
- Assay & Drug Development Technologies, 2023, v. 21, n. 8, p. 385, doi. 10.1089/adt.2023.125
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications January–March 2023.
- Published in:
- Assay & Drug Development Technologies, 2023, v. 21, n. 4, p. 180, doi. 10.1089/adt.2023.030
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications October–December 2022.
- Published in:
- Assay & Drug Development Technologies, 2023, v. 21, n. 2, p. 80, doi. 10.1089/adt.2023.008
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July–September 2022.
- Published in:
- Assay & Drug Development Technologies, 2022, v. 20, n. 8, p. 359, doi. 10.1089/adt.2022.097
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications March–June 2022.
- Published in:
- Assay & Drug Development Technologies, 2022, v. 20, n. 6, p. 286, doi. 10.1089/adt.2022.065
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications January–March 2022.
- Published in:
- Assay & Drug Development Technologies, 2022, v. 20, n. 4, p. 183, doi. 10.1089/adt.2022.033
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July–September 2021.
- Published in:
- Assay & Drug Development Technologies, 2022, v. 20, n. 1, p. 35, doi. 10.1089/adt.2021.126
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April–June 2021.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 7, p. 463, doi. 10.1089/adt.2021.095
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications January–March 2021.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 5, p. 300, doi. 10.1089/adt.2021.051
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications October–December 2020.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 3, p. 209, doi. 10.1089/adt.2021.005
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July–September 2020.
- Published in:
- Assay & Drug Development Technologies, 2021, v. 19, n. 3, p. 204, doi. 10.1089/adt.2020.1072
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April–June 2020.
- Published in:
- Assay & Drug Development Technologies, 2020, v. 18, n. 8, p. 385, doi. 10.1089/adt.2020.1019
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications October–December 2019.
- Published in:
- Assay & Drug Development Technologies, 2020, v. 18, n. 5, p. 243, doi. 10.1089/adt.2020.974
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July–September 2019.
- Published in:
- Assay & Drug Development Technologies, 2020, v. 18, n. 4, p. 202, doi. 10.1089/adt.2019.969
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April–June 2019.
- Published in:
- Assay & Drug Development Technologies, 2020, v. 18, n. 3, p. 148, doi. 10.1089/adt.2019.968
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April-June 2016.
- Published in:
- Assay & Drug Development Technologies, 2016, v. 14, n. 10, p. 573, doi. 10.1089/adt.2016.29052.pq2
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July-September 2016.
- Published in:
- Assay & Drug Development Technologies, 2016, v. 14, n. 10, p. 577, doi. 10.1089/adt.2016.29053.pq3
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications April-June 2015.
- Published in:
- Assay & Drug Development Technologies, 2015, v. 13, n. 10, p. 654, doi. 10.1089/adt.2015.29030.pq2
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications July-September 2015.
- Published in:
- Assay & Drug Development Technologies, 2015, v. 13, n. 10, p. 661, doi. 10.1089/adt.2015.29031.pq3
- By:
- Publication type:
- Article
Drug Repurposing Patent Applications January-March 2015.
- Published in:
- Assay & Drug Development Technologies, 2015, v. 13, n. 6, p. 332, doi. 10.1089/adt.2015.29017.patdrrr
- By:
- Publication type:
- Article
COVID-19 Tedavisinde Kullanılan İlaçların Biyofarmasötik, Farmakokinetik ve Patent Değerlendirmeleri: Ülkemizde Eşdeğer İlaçların Geliştirilmesindeki Güncel Durum.
- Published in:
- Gazi Medical Journal, 2020, v. 31, p. 498, doi. 10.12996/gmj.2020.119
- By:
- Publication type:
- Article
Adverse Event Profile of First-line Drugs for Treating Patent Ductus Arteriosus in Neonates: A Disproportionality Analysis Study of USFDA Adverse Event Reporting System.
- Published in:
- Pediatric Drugs, 2024, v. 26, n. 6, p. 767, doi. 10.1007/s40272-024-00657-3
- By:
- Publication type:
- Article
Analysis of the evolution of the price of oncology drugs after the loss of their patent and the marketing of generic medicines.
- Published in:
- Global & Regional Health Technology Assessment, 2022, v. 9, n. 1, p. 68, doi. 10.33393/grhta.2022.2366
- By:
- Publication type:
- Article
DRUGS, PATENTS, AND WELL-BEING.
- Published in:
- Washington University Law Review, 2021, v. 98, n. 5, p. 1403
- By:
- Publication type:
- Article
Evolution of the emergency drug innovation network and policy implications: Evidence from COVID-19 drug patents.
- Published in:
- Science & Public Policy (SPP), 2022, v. 49, n. 3, p. 403, doi. 10.1093/scipol/scab087
- By:
- Publication type:
- Article
Novartis tells SC it has right to patent blood cancer drug.
- Published in:
- Journal of Intellectual Property Rights, 2011, v. 16, n. 5, p. 438
- Publication type:
- Article